Louisiana Mesothelioma Fact Sheet
While mesothelioma is a problem in all states, the specific incident rate for Louisiana is 1.3 / 100,000. This is above the average rate of 1.1 / 100,000. Click on the tabs below to find mesothelioma and asbestos research in LA, recent LA mesothelioma-related court cases, mesothelioma specialists in LA and potential asbestos hotspots in Louisiana.
Louisiana Mesothelioma Info
By clicking on the above tabs, you will find information on mesothelioma specific to the state of Louisiana
Louisiana Research and Clinical Trials
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Louisiana Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Louisiana Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
This is a partial list of scientific or medical grants in your state for research into mesothelioma and related illnesses.
Louisiana Doctors and Hospitals
This is a partial list of hospitals and physicians that reportedly treat mesothelioma patients in your state.
Louisiana Cases
This is a partial list of relevant court cases on mesothelioma in your state.
Disclaimer: Inclusion on this directory does not constitute endorsement by Cancer Monthly, Inc. All physicians who appear in this section do so based on their own expression of interest in the fields of mesothelioma treatment. Cancer Monthly, Inc. has not verified the competence, professional credentials, business practices or validity of the expressed interests of these physicians. Cancer Monthly makes no recommendation of any physician on this list and makes no suggestion that any such physician will cure or prevent any disease. Those consulting a physician on this list should approach the consultation exactly as they would with any other unknown physician.
Rando v. Anco Insulations Inc.
No. 08-C-1163 C/w 08-C-1169, SUPREME COURT OF LOUISIANA, May 22, 2009, Decided
No. 08-C-1163 C/w 08-C-1169, SUPREME COURT OF LOUISIANA, May 22, 2009, Decided
Cichirillo v. Avondale Indus.
No. 04-C-2894 C/w No. 04-C-2918 , SUPREME COURT OF LOUISIANA, November 29, 2005, Decided
No. 04-C-2894 C/w No. 04-C-2918 , SUPREME COURT OF LOUISIANA, November 29, 2005, Decided
Landry v. Avondale Indus.
Nos. 03-CC-3432, 03-CC-3434, 03-CC-3435 , SUPREME COURT OF LOUISIANA , July 2, 2004, Decided
Nos. 03-CC-3432, 03-CC-3434, 03-CC-3435 , SUPREME COURT OF LOUISIANA , July 2, 2004, Decided
Landry v. Avondale Indus.
No. 03-CC-0719 C/w No. 03-CC-0993 C/w No. 03-CC-1002 , SUPREME COURT OF LOUISIANA, December 3, 2003, Decided
No. 03-CC-0719 C/w No. 03-CC-0993 C/w No. 03-CC-1002 , SUPREME COURT OF LOUISIANA, December 3, 2003, Decided
Bonnette v. Conoco, Inc.
No. 2001-C-2767 , SUPREME COURT OF LOUISIANA, January 28, 2003, Decided
No. 2001-C-2767 , SUPREME COURT OF LOUISIANA, January 28, 2003, Decided
Estate of Patrick v. Bd. of Supervisors
No. 02-CC-2570 , SUPREME COURT OF LOUISIANA, November 22, 2002, Decided
No. 02-CC-2570 , SUPREME COURT OF LOUISIANA, November 22, 2002, Decided
Austin v. Abney Mills
No. 2001-C-1598 , SUPREME COURT OF LOUISIANA, September 4, 2002, Decided
No. 2001-C-1598 , SUPREME COURT OF LOUISIANA, September 4, 2002, Decided
Ruckstuhl v. Owens Corning Fiberglas Corp.
No. 98-CC-1126, SUPREME COURT OF LOUISIANA, April 13, 1999, Decided
No. 98-CC-1126, SUPREME COURT OF LOUISIANA, April 13, 1999, Decided
Boudreaux v. Able Supply Co.
08-1350, COURT OF APPEAL OF LOUISIANA, THIRD CIRCUIT, October 7, 2009, Decided
08-1350, COURT OF APPEAL OF LOUISIANA, THIRD CIRCUIT, October 7, 2009, Decided
Hymel v. Eagle, Inc.
NO. 2008-CA-1287, COURT OF APPEAL OF LOUISIANA, FOURTH CIRCUIT, March 19, 2009, Decided
NO. 2008-CA-1287, COURT OF APPEAL OF LOUISIANA, FOURTH CIRCUIT, March 19, 2009, Decided
Hospitals and Cancer Centers
We do not have any doctors or cancer centers for this state at the moment.
We do not have any doctors or cancer centers for this state at the moment.
| City | Site |
| Alexandria |
Sheraton |
| Avondale |
Avondale Shipyard |
| Baton Rouge |
Co-Parliament Rubber Pant Dow Chemical Exxon Chemical Gulf Intercoastal Marine Gulf State Utility Oil Refinery Shell Oil Refinery Texaco Refinery |
| Bellechase |
Chevron Oil Refinery |
| Beras |
Williams Oil Drilling Company |
| Bossier City |
BIC Institutional Foods Sheraton |
| Denham Springs |
Wilson Steel |
| Donaldson |
Gulf Chemical |
| Faraday |
Concordia Trade School |
| Fort Hudson |
International Paper Company |
| Franklin |
Carbon Black Plant |
| Geismar |
Shell Refinery |
| Geismbr |
Bordan Chemical |
| Gretna |
Gulf Atlanta Refinery |
| Gulfport |
Teledyne Irby Steel |
| Harvey |
A-1 Industries |
| Hodge |
Stone Container |
| Joliet |
Amoco Chemical Standard |
| La Place |
Good Hope Oil Refinery |
| Lafayette |
Southwestern School St Elizabeth Hospital |
| Lake Charles |
Cities Service Oil Refinery Conoco Refinery Continental Oil Refinery Lake Charles Power Plant Phillips Cit-Con Refinery PPG Chemical Citgo Refinery |
| Logansport |
RiteCare Processing Plant |
| Luling |
Union Carbide |
| Mandeville |
Schott Chotin |
| Marrero |
Johns-Manville |
| Monroe |
Enrcio Ferme Power Plant |
| New Orleans |
American Marine Shipyard Avondale Shipyard Calmes Shipyard Dow Chemical Gulf Oil Refinery Higgins Shipyard Shell Oil Refinery Southwest Steel Texaco Refinery Todd Shipyard US Coast Guard Base |
| Paradise |
Texaco Oil Refinery |
| Placida |
Dow Chemical |
| Plaquemine |
Georgia Pacific Plant |
| Point Nechester |
Texaco Refinery |
| Port Hudson |
Port Hudson Paper Mill |
| Reserve |
Godchioux Sugar |
| Schwartz |
Columbia Carbon |
| Slidell |
Canulette Shipyard Southern Shipyard Superior Shipyards |
| Springhill |
International Paper Company |
| Taft |
Union Carbide |
| Thibodeaux |
Urby's Care Farm |
Research
Schwarzenberger, Paul O. Treatment Of Malignant Pleural Mesothelioma W/ Gene Modified Cancer Cell Lines
Grant: 2M01RR005096-10A10317
Grant: 2M01RR005096-10A10317
Abstract: Malignant mesothelioma is a lung cancer originating from the pleura and is caused by occupational exposure to asbestos. Mesothelioma is highly overrepresented in South East Louisiana, specifically the New Orleans area. The city had a large shipyard industry and one of the largest asbestos manufacturing plants in the country; it has a disproportionately large incidence of this disease. There is no satisfactory treatment for this cancer and it is almost universally fatal, regardless of the stage of the tumor at the time of diagnosis. Current treatment modalities include surgery, chemotherapy, and radiation therapy, although in some series none of these modalities is superior to no treatment at all. Because of the dismal prognosis for patients with malignant mesothelioma, a new mode of treatment is desperately needed. A promising area of research into the treatment of various malignancies is gene therapy. Recent studies have demonstrated the utility of exposing tumor cells to cells transduced to express the Herpes simplex virus gene for thymidine kinase (HSV-TK). By virtue of their expression of HSV-TK, the transduced cells are rendered susceptible to the antiviral drug, ganciclovir (GCV). Nearby tumor cells are killed by a so-called bystander effect. In this protocol, we propose a Phase I trial to introduce HSV-TK transduced ovarian cancer cells into the pleural cavities of patients with malignant pleural mesothelioma, followed by systemic administration of ganciclovir. The hope is that administration of ganciclovir will result in killing of the transduced ovarian cancer cells as well as the nearby malignant mesothelioma cells.
Tags: Cell Line, Gene Therapy, Human Therapy Evaluation, Mesothelioma, Neoplasm /cancer Therapy Clinical Trial Phase I, Clinical Trial Phase Ii /iii /iv Clinical Research, Human Subject
Tags: Cell Line, Gene Therapy, Human Therapy Evaluation, Mesothelioma, Neoplasm /cancer Therapy Clinical Trial Phase I, Clinical Trial Phase Ii /iii /iv Clinical Research, Human Subject
- Followup Grant: 5M01RR005096-090317
- Followup Grant: 3M01RR005096-09S10317
- Followup Grant: 5M01RR005096-120317
- Followup Grant: 5M01RR005096-140317
Clinical Trials
Condition: Malignant Mesothelioma
Intervention: Biological: PA-1-STK ovarian carcinoma vaccine; Drug: ganciclovir
More Information
Intervention: Biological: PA-1-STK ovarian carcinoma vaccine; Drug: ganciclovir
More Information
Condition: Malignant Mesothelioma
Intervention: Drug: cisplatin; Drug: gemcitabine hydrochloride
More Information
Intervention: Drug: cisplatin; Drug: gemcitabine hydrochloride
More Information
Condition: Malignant Mesothelioma
Intervention: Drug: epirubicin hydrochloride; Drug: gemcitabine hydrochloride
More Information
Intervention: Drug: epirubicin hydrochloride; Drug: gemcitabine hydrochloride
More Information
Condition: Mesothelioma; Lung Cancer
Intervention: Drug: Comparator: Suberoylanilide Hydroxamic Acid (Vorinostat, MK0683); Drug: Comparator: Placebo
More Information
Intervention: Drug: Comparator: Suberoylanilide Hydroxamic Acid (Vorinostat, MK0683); Drug: Comparator: Placebo
More Information
Condition: Malignant Mesothelioma
Intervention: Biological: recombinant interferon alfa; Drug: cisplatin; Procedure: surgical procedure; Radiation: radiation therapy
More Information
Intervention: Biological: recombinant interferon alfa; Drug: cisplatin; Procedure: surgical procedure; Radiation: radiation therapy
More Information
Have questions about mesothelioma?
If you want answers right now call our Mesothelioma Resource Specialist - Abby Palmer, MSW.
She takes calls throughout the day and early evening. Her number is: 619-261-7922.
She is not a doctor and does not provide medical advice.
DISCLAIMER: Surviving Mesothelioma® is registered with the United States Patent and Trademark Office by Cancer Monthly, Inc. and the website is owned and managed by Cancer Monthly Inc. All of the information provided on this website is for informational purposes only. Neither Cancer Monthly nor this website renders medical advice or professional services. The information provided by Abby Palmer or any other employee or contractor of Cancer Monthly, Inc. is not to be considered medical advice and is not intended to replace consultation with a qualified medical professional. You should consult a qualified health care provider for medical advice and answers to personal health questions. The responsibility of your disease management plan is with your treating physicians and you should only follow your treating physician’s advice. DO NOT change or modify your disease management plan on your own without consulting your treating physicians. This website is not a substitute for professional medical advice, examination, diagnosis or treatment. This website should not be used for diagnosing or treating a health problem or disease and it is not a substitute for professional care. You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. You should not delay in seeking or disregard medical advice based on information on this website. Some information may be out of date. The information on this website is intended to convey general information only. It should not be construed as legal advice or opinion. This website and its contents are not intended to create an attorney-client relationship. You should not act on or rely on any information on this website without seeking the advice of an attorney. You are encouraged to promptly speak to legal counsel to identify and protect your legal rights and any deadlines for filing a claim or lawsuit. People who request a free book may be called to verify their address and to introduce other mesothelioma resources that are available.